Market - Page 301 of 329 - Express Pharma

Marck Biosciences takes private equity route with Tata Capital

Glenmark initiates IND enabling studies of novel monoclonal antibody targeting OX40

M&A activity in pharma sector focuses on expanding product offerings

STEM-2013 redefines stem cell research in India

GIPC-2013 sees congregation of IP experts

Bangalore INDIA BIO 2013 ends on a promising note

High Potent Drugs-2013 debates regulatory complexities

#Socialmedia: Trending in Indian pharma

‘The next 3-5 years would see stem cell banking penetration rise above 1 per cent’

Evolva in collaboration with Ajinomoto